Literature DB >> 14625020

Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice.

Hiroyasu Inoue1, Xiao Fan Jiang, Takahiro Katayama, Shiho Osada, Kazuhiko Umesono, Shobu Namura.   

Abstract

Peroxisome proliferator-activated receptors (PPARs) are ligand-dependent transcription factors which belong to the nuclear receptor family. We examined whether PPARalpha agonists and resveratrol, a polyphenol contained in grapes, protect the brain against ischemia. To investigate whether resveratrol activates PPARs, we performed a cell-based transfection activity assay using luciferase reporter plasmid. PPARalpha and PPARgamma were activated by resveratrol in primary cortical cultures and vascular endothelial cells. Resveratrol (20 mg/kg, 3 days) reduced infarct volume by 36% at 24 h after middle cerebral artery occlusion in wild-type mice. The PPARalpha agonists fenofibrate (30 mg/kg, 3 days) and Wy-14643 (30 mg/kg, days) exerted similar brain protection. However, resveratrol and fenofibrate failed to protect the brain in PPARalpha knockout mice. The data indicate that PPARalpha agonists protect the brain through PPARalpha.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14625020     DOI: 10.1016/j.neulet.2003.09.001

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  69 in total

1.  The PPAR alpha agonist gemfibrozil is an ineffective treatment for spinal cord injured mice.

Authors:  Akshata Almad; A Todd Lash; Ping Wei; Amy E Lovett-Racke; Dana M McTigue
Journal:  Exp Neurol       Date:  2011-09-21       Impact factor: 5.330

Review 2.  Are sirtuins viable targets for improving healthspan and lifespan?

Authors:  Joseph A Baur; Zoltan Ungvari; Robin K Minor; David G Le Couteur; Rafael de Cabo
Journal:  Nat Rev Drug Discov       Date:  2012-06-01       Impact factor: 84.694

Review 3.  Resveratrol neuroprotection in stroke and traumatic CNS injury.

Authors:  Mary S Lopez; Robert J Dempsey; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2015-08-12       Impact factor: 3.921

Review 4.  Involvement of PPAR nuclear receptors in tissue injury and wound repair.

Authors:  Liliane Michalik; Walter Wahli
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

Review 5.  Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury.

Authors:  Rosanna Di Paola; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-03-13       Impact factor: 3.000

6.  PPARalpha ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF-kappaB and AP-1 pathways.

Authors:  Sriram Ramanan; Mitra Kooshki; Weiling Zhao; Fang-Chi Hsu; Mike E Robbins
Journal:  Free Radic Biol Med       Date:  2008-09-17       Impact factor: 7.376

7.  Various Terpenoids Derived from Herbal and Dietary Plants Function as PPAR Modulators and Regulate Carbohydrate and Lipid Metabolism.

Authors:  Tsuyoshi Goto; Nobuyuki Takahashi; Shizuka Hirai; Teruo Kawada
Journal:  PPAR Res       Date:  2010-06-03       Impact factor: 4.964

8.  Vaticanol C, a resveratrol tetramer, activates PPARalpha and PPARbeta/delta in vitro and in vivo.

Authors:  Tomoko Tsukamoto; Rieko Nakata; Emi Tamura; Yukiko Kosuge; Aya Kariya; Michiko Katsukawa; Satoshi Mishima; Tetsuro Ito; Munekazu Iinuma; Yukihiro Akao; Yoshinori Nozawa; Yuji Arai; Shobu Namura; Hiroyasu Inoue
Journal:  Nutr Metab (Lond)       Date:  2010-05-27       Impact factor: 4.169

9.  Aqueous cinnamon extract (ACE-c) from the bark of Cinnamomum cassia causes apoptosis in human cervical cancer cell line (SiHa) through loss of mitochondrial membrane potential.

Authors:  Soumya J Koppikar; Amit S Choudhari; Snehal A Suryavanshi; Shweta Kumari; Samit Chattopadhyay; Ruchika Kaul-Ghanekar
Journal:  BMC Cancer       Date:  2010-05-18       Impact factor: 4.430

10.  Role of PPARs in Radiation-Induced Brain Injury.

Authors:  Sriram Ramanan; Weiling Zhao; David R Riddle; Mike E Robbins
Journal:  PPAR Res       Date:  2009-09-17       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.